Modifi Bio Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 12

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $30M

Modifi Bio General Information

Description

Developer of oncology therapeutics platform intended to exploit DNA defects in a wide range of cancer cells. The company's approach to fighting cancer is based on its ability to modify tumor DNA in a manner that is irreparable to cancer cells, without negatively impacting healthy cells, enabling researchers to disrupt conventional oncology drug development.

Contact Information

Website
www.modifibio.com
Formerly Known As
Aztek Bio, KL50 Therapeutics
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 55 Church Street
  • New Haven, CT 06510
  • United States
Primary Industry
Biotechnology
Acquirer
Merck
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • 55 Church Street
  • New Haven, CT 06510
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Modifi Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 15-Oct-2024 $30M Completed Generating Revenue
3. Seed Round 29-Aug-2024 Completed Pre-Clinical Trials
2. Seed Round 02-Aug-2023 $11M $11M Completed Pre-Clinical Trials
1. Grant 25-Oct-2022 $2.4M Completed Pre-Clinical Trials
To view Modifi Bio’s complete valuation and funding history, request access »

Modifi Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of oncology therapeutics platform intended to exploit DNA defects in a wide range of cancer cells. The company
Biotechnology
New Haven, CT
12 As of 2024

New Haven, CT
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Modifi Bio Competitors (2)

One of Modifi Bio’s 2 competitors is Cybrexa Therapeutics, a Venture Capital-Backed company based in New Haven, CT.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cybrexa Therapeutics Venture Capital-Backed New Haven, CT
Carrick Therapeutics Venture Capital-Backed Boston, MA
You’re viewing 2 of 2 competitors. Get the full list »

Modifi Bio Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 3

    Pending

  • Expiring in next 12 mo

Modifi Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024321675-A1 Fluoroalkoxyalkylene-dihydroimidazo[5,1-d]tetrazinone compounds and related compounds and their use in treating medical conditions Pending 04-Aug-2023
EP-4754104-A1 Fluoroalkoxyalkylene-dihydroimidazo[5,1-d]tetrazinone compounds and related compounds and their use in treating medical conditions Pending 04-Aug-2023
US-20250066371-A1 Fluoroalkoxyalkylene-dihydroimidazo[5,1-d]tetrazinone compounds and related compounds and their use in treating medical conditions Pending 04-Aug-2023
WO-2025034537-A1 Fluoroalkoxyalkylene-dihydroimidazo[5,1-d]tetrazinone compounds and related compounds and their use in treating medical conditions Inactive 04-Aug-2023 C07D487/04

Modifi Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Modifi Bio Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
ACS BrightEdge Corporate Venture Capital Minority
Connecticut Innovations Venture Capital Minority
HighCape Capital Growth/Expansion Minority
Ironwood Capital Growth/Expansion Minority
National Brain Tumor Society Not-For-Profit Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

Modifi Bio FAQs

  • When was Modifi Bio founded?

    Modifi Bio was founded in 2014.

  • Where is Modifi Bio headquartered?

    Modifi Bio is headquartered in New Haven, CT.

  • What is the size of Modifi Bio?

    Modifi Bio has 12 total employees.

  • What industry is Modifi Bio in?

    Modifi Bio’s primary industry is Biotechnology.

  • Is Modifi Bio a private or public company?

    Modifi Bio is a Private company.

  • What is the current valuation of Modifi Bio?

    The current valuation of Modifi Bio is .

  • What is Modifi Bio’s current revenue?

    The current revenue for Modifi Bio is .

  • How much funding has Modifi Bio raised over time?

    Modifi Bio has raised $12M.

  • Who are Modifi Bio’s investors?

    ACS BrightEdge, Connecticut Innovations, HighCape Capital, Ironwood Capital, and National Brain Tumor Society are 5 of 9 investors who have invested in Modifi Bio.

  • Who are Modifi Bio’s competitors?

    Cybrexa Therapeutics and Carrick Therapeutics are competitors of Modifi Bio.

  • When was Modifi Bio acquired?

    Modifi Bio was acquired on 15-Oct-2024.

  • Who acquired Modifi Bio?

    Modifi Bio was acquired by Merck.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process